Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Parkinson disease”

Study on Preliminary Safety and Efficacy of the ARC-IM Therapy to Alleviate Locomotor Deficits in People With Parkinson's DiseaseRecruiting
NCT06295614NAUpdated Jun 4, 2026
Sponsor: Ecole Polytechnique Fédérale de Lausanne
Parkinson Disease
Switzerland
The Meals Study for Amyotrophic Lateral Sclerosis and Parkinson's DiseaseCompleted
NCT07625605NAUpdated Jun 4, 2026
Sponsor: The University of Tennessee, Knoxville
Amyotrophic Lateral Sclerosis (ALS) · Parkinson's Disease (PD)
United States
Study of PF-07265807 in Participants With Metastatic Solid Tumors.Terminated
NCT04458259Phase 1Updated Jun 4, 2026
Sponsor: Pfizer
Neoplasm Metastasis
United States, Canada, Italy, Japan, Spain
Behavioral Intervention for Lifestyle Physical Activity in Parkinson's DiseaseNot Yet Recruiting
NCT06603012NAUpdated Jun 4, 2026
Sponsor: University of Illinois at Chicago
Parkinson Disease (PD)
United States
Blood Flow Restriction and Exercise in Parkinson's DiseaseCompleted
NCT07221994NAUpdated Jun 4, 2026
Sponsor: University of California, San Francisco
Parkinson' Disease
United States
Pilot Deprescribing of Antimuscarinic Overactive Bladder Medications in Parkinson DiseaseNot Yet Recruiting
NCT07627529Phase 4Updated Jun 4, 2026
Sponsor: Corporal Michael J. Crescenz VA Medical Center
Parkinson Disease (PD)
United States
Evaluation of the Pharmacokinetics, Biodistribution and Radiation Dosimetry of [18F]MODAG-009 Positron Emission Tomography (PET) Radiotracers in Adult Healthy VolunteersRecruiting
NCT07617688EARLY_Phase 1Updated Jun 4, 2026
Sponsor: MODAG GmbH
Healthy Adult
United States
Biomechanical Effects of EMST® on Swallowing Function in Parkinson's DiseaseRecruiting
NCT07606547NAUpdated Jun 3, 2026
Sponsor: University Hospital Muenster
Parkinson's Disease (PD) · Dysphagia
Germany
Occupational Therapy Led Social Prescription for People With Parkinson DiseaseActive Not Recruiting
NCT06447207NAUpdated Jun 3, 2026
Sponsor: Colorado State University
Parkinson Disease
United States
Feasibility of a Community-Based Multimodal Exercise Programme in Parkinson's DiseaseRecruiting
NCT07618728NAUpdated Jun 3, 2026
Sponsor: Universidad Rey Juan Carlos
PARKINSON DISEASE (Disorder)
Spain
Subthalamic Steering for Therapy Optimization in Parkinson's DiseaseCompleted
NCT03548506NAUpdated Jun 3, 2026
Sponsor: University Hospital Tuebingen
Parkinson Disease
Germany
Dysarthria Management for Minor GroupsActive Not Recruiting
NCT06593860NAUpdated Jun 3, 2026
Sponsor: Florida State University
Parkinson Disease · Dysarthria
United States
Effects of Dual-Task Training on Upper Extremity Function in Parkinson's DiseaseRecruiting
NCT07536542NAUpdated Jun 2, 2026
Sponsor: Ankara University
Parkinson Disease (PD)
Turkey (Türkiye)
Mindfulness Meditation (MBSR) and Parkinson's Disease (PD)Completed
NCT05180643NAUpdated Jun 2, 2026
Sponsor: University Hospital, Bordeaux
Parkinson Disease
France
Developing Precision Microbiota-Based Cocktail Modification Therapy to Delay the Progression of Parkinson's Disease (PD) - Use Preclinical Human Trials to Confirm the Impact of the Optimal "Probiotic Y7, Tryptophan and Branched-chain Amino Acid" Cocktail Formula on Early Stage PD PatientsRecruiting
NCT07619560NAUpdated Jun 2, 2026
Sponsor: Taipei Medical University
Parkinson Disease (PD) · Gut Microbiota · Probiotic
Taiwan
Relative Bioavailability Study of HNC364 Injectable SuspensionActive Not Recruiting
NCT06798519Phase 1Updated Jun 2, 2026
Sponsor: Guangzhou Henovcom Bioscience Co. Ltd.
Parkinson's Disease (PD)
United States
Study on Feasibility of Targeted Epidural Spinal Stimulation (TESS) to Improve Mobility in Patients With Parkinson's DiseaseCompleted
NCT04956770NAUpdated Jun 1, 2026
Sponsor: Jocelyne Bloch
Parkinson Disease
Switzerland
Safety and Efficacy Study of Investigational Agents as Monotherapy or in Combination With Pembrolizumab (MK-3475) for the Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Need of Second-Line Therapy (MK-3475-B98/KEYNOTE-B98)Active Not Recruiting
NCT04938817Phase 1, Phase 2Updated Jun 1, 2026
Sponsor: Merck Sharp & Dohme LLC
Small Cell Lung Carcinoma
United States, Australia, Austria, Canada, Hungary +7 more
Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinson's DiseaseCompleted
NCT04750226Phase 3Updated Jun 1, 2026
Sponsor: AbbVie
Parkinson's Disease (PD)
United States, Australia
Dyadic Mindfulness for People With Parkinson's Disease and Their CaregiversRecruiting
NCT06821230NAUpdated Jun 1, 2026
Sponsor: The University of Hong Kong
Mindfulness · Caregivers · Movement Disorders · Neurodegenerative Disease
Hong Kong
Wearable Assessments in the Clinic and Home in PDCompleted
NCT03681015N/AUpdated Jun 1, 2026
Sponsor: University of Rochester
Parkinson Disease
United States
Results of Combined Medical and Swallowing Behavioral Readjustment Therapy in Oropharyngeal Dysphagia Management Among Parkinson's PatientsCompleted
NCT07618637NAUpdated Jun 1, 2026
Sponsor: Tanta University
Oropharyngeal Dysphagia (OPD) · Parkinson · Swallowing Difficulties
Egypt
Imaging Core Aim 2, and Udall Project 2 Aim 2Recruiting
NCT06998303NAUpdated May 29, 2026
Sponsor: University of Minnesota
Parkinson Disease
United States
Cognitive Decline Following Deep Brain StimulationRecruiting
NCT05822388N/AUpdated May 29, 2026
Sponsor: Medical University of South Carolina
Parkinson Disease · Movement Disorders
United States
Evaluation of the Impact of Virtual Park on Training Motivation in Adult PatientsNot Yet Recruiting
NCT07616050NAUpdated May 29, 2026
Sponsor: Marta Mondellini
Post-stroke · Parkinson Disease · Amyotrophic Lateral Sclerosis · Mild Cognitive Impairment (MCI)
Italy

Previous page Next page